IL6 and colonic neoplasm: Taken together, the AC serum effectively relieved the indicators of inflammation and down-regulating the expression of colon cancer biomarker CXCL8 as determined by bioinformatics analysis but has no impact on another pro-inflammatory chemokine IL6.